Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi
Public ClinicalTrials.gov record NCT00634049. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-label Study of Isavuconazole in the Treatment of Participants With Aspergillosis and Renal Impairment or of Participants With Invasive Fungal Disease Caused by Rare Moulds, Yeasts or Dimorphic Fungi
Study identification
- NCT ID
- NCT00634049
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Astellas Pharma Inc
- Industry
- Enrollment
- 149 participants
Conditions and interventions
Conditions
Interventions
- isavuconazole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 21, 2008
- Primary completion
- Jan 2, 2014
- Completion
- May 4, 2016
- Last update posted
- Dec 10, 2024
2008 – 2016
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| City Of Hope National Medical Center | Duarte | California | 91010 | — |
| University of California Davis Health System | Sacramento | California | 95817 | — |
| California Pacific Medical Center | San Francisco | California | 94110 | — |
| University of California at San Francisco | San Francisco | California | 94143 | — |
| Stanford University Hospital | Stanford | California | 94303 | — |
| University Of Colorado Health Sciences Center | Aurora | Colorado | 80045 | — |
| Emory Hospital | Atlanta | Georgia | 30322 | — |
| University of Chicago, Division of Infectious Diseases | Chicago | Illinois | 60637 | — |
| Indiana BMT | Beech Grove | Indiana | 46107 | — |
| Infectious Disease of Indiana | Indianapolis | Indiana | 46280 | — |
| Ochsner Clinic Foundation | New Orleans | Louisiana | 70121 | — |
| Brigham & Womens Hospital | Boston | Massachusetts | 02115 | — |
| UMASS Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| Wayne State University School of Medicine | Detroit | Michigan | 48201 | — |
| Henry Ford Hospital | Detroit | Michigan | 48202 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| Upstate Infectious Diseases Association LLP | Albany | New York | 12208 | — |
| Cleveland Clinic | Cleveland | Ohio | 44195 | — |
| Regional Infection Diseases Infusion Center Inc. | Lima | Ohio | 45801 | — |
| Temple University Health Sciences | Philadelphia | Pennsylvania | 19140 | — |
| University of Pittsburgh Medical Center Health System | Pittsburgh | Pennsylvania | 15213 | — |
| University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Fred Hutchinson Cancer Research Center, Clinical Research | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 72 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00634049, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 10, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00634049 live on ClinicalTrials.gov.